These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 15860217
1. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Takahashi H, Numasaki M, Lotze MT, Sasaki H. Immunol Lett; 2005 May 15; 98(2):189-93. PubMed ID: 15860217 [Abstract] [Full Text] [Related]
2. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor. Kaga T, Kawano H, Sakaguchi M, Nakazawa T, Taniyama Y, Morishita R. Vascul Pharmacol; 2012 Aug 19; 57(1):3-9. PubMed ID: 22361334 [Abstract] [Full Text] [Related]
3. Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts. Numasaki M, Lotze MT, Sasaki H. Immunol Lett; 2004 Apr 30; 93(1):39-43. PubMed ID: 15134897 [Abstract] [Full Text] [Related]
4. Roles of cyclooxygenase-2 in microvascular endothelial cell proliferation induced by basic fibroblast growth factor. Qian RZ, Yue F, Zhang GP, Hou LK, Wang XH, Jin HM. Chin Med J (Engl); 2008 Dec 20; 121(24):2599-603. PubMed ID: 19187602 [Abstract] [Full Text] [Related]
5. Heterogeneity of capillary endothelial cells for basic fibroblast growth factor-induced paracrine signaling. Lee TH, Lee HC, Son YS, Kang MA, Park MJ, Nam MJ, Lee SH, Hong SI. Endothelium; 2006 Dec 20; 13(3):191-203. PubMed ID: 16840175 [Abstract] [Full Text] [Related]
6. VEGF-A, HGF and bFGF are Involved in IL-17A-mediated Migration and Capillary-like Vessel Formation of Vascular Endothelial Cells. Numasaki M, Ito K. Iran J Immunol; 2021 Jun 20; 18(2):103-110. PubMed ID: 34190691 [Abstract] [Full Text] [Related]
7. Basic fibroblast growth factor stimulates hepatocyte growth factor/scatter factor secretion by human mesenchymal cells. Roletto F, Galvani AP, Cristiani C, Valsasina B, Landonio A, Bertolero F. J Cell Physiol; 1996 Jan 20; 166(1):105-11. PubMed ID: 8557758 [Abstract] [Full Text] [Related]
8. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma. Worden B, Yang XP, Lee TL, Bagain L, Yeh NT, Cohen JG, Van Waes C, Chen Z. Cancer Res; 2005 Aug 15; 65(16):7071-80. PubMed ID: 16103054 [Abstract] [Full Text] [Related]
9. Hepatocyte growth factor is a major mediator in heparin-induced angiogenesis. Okada M, Matsumori A, Ono K, Miyamoto T, Takahashi M, Sasayama S. Biochem Biophys Res Commun; 1999 Feb 05; 255(1):80-7. PubMed ID: 10082659 [Abstract] [Full Text] [Related]
10. Nitric oxide suppresses the secretion of vascular endothelial growth factor and hepatocyte growth factor from human mesenchymal stem cells. Wang Y, Crisostomo PR, Wang M, Weil B, Abarbanell A, Poynter J, Manukyan MC, Meldrum DR. Shock; 2008 Nov 05; 30(5):527-31. PubMed ID: 18391852 [Abstract] [Full Text] [Related]
11. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells. Xu Z, Maiti D, Kisiel W, Duh EJ. Arterioscler Thromb Vasc Biol; 2006 Dec 05; 26(12):2819-25. PubMed ID: 17023682 [Abstract] [Full Text] [Related]
12. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases. Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH. Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973 [Abstract] [Full Text] [Related]
13. Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cells. Deissler HL, Deissler H, Lang GE. Br J Ophthalmol; 2011 Aug 15; 95(8):1151-6. PubMed ID: 21273213 [Abstract] [Full Text] [Related]
14. Influence of hepatocyte growth factor/scatter factor (HGF/SF) on fibroblast growth factor-2 (FGF-2) levels in external auditory canal cholesteatoma (EACC) cell culture. Naim R, Chang RC, Sadick H, Hormann K. In Vivo; 2005 Aug 15; 19(3):599-603. PubMed ID: 15875782 [Abstract] [Full Text] [Related]
15. Differences in the temporal expression of regulatory growth factors during choroidal neovascular development. Hu W, Criswell MH, Fong SL, Temm CJ, Rajashekhar G, Cornell TL, Clauss MA. Exp Eye Res; 2009 Jan 15; 88(1):79-91. PubMed ID: 19013152 [Abstract] [Full Text] [Related]
16. Tetrathiomolybdate blocks bFGF- but not VEGF-induced incipient angiogenesis in vitro. Mamou F, May KS, Schipper MJ, Gill N, Kariapper MS, Nair BM, Brewer G, Normolle D, Khan MK. Anticancer Res; 2006 Jan 15; 26(3A):1753-8. PubMed ID: 16827103 [Abstract] [Full Text] [Related]
17. Angiogenic synergy of bFGF and VEGF is antagonized by Angiopoietin-2 in a modified in vivo Matrigel assay. Ley CD, Olsen MW, Lund EL, Kristjansen PE. Microvasc Res; 2004 Nov 15; 68(3):161-8. PubMed ID: 15501235 [Abstract] [Full Text] [Related]
18. Activated human neutrophils release hepatocyte growth factor/scatter factor. McCourt M, Wang JH, Sookhai S, Redmond HP. Eur J Surg Oncol; 2001 Jun 15; 27(4):396-403. PubMed ID: 11417987 [Abstract] [Full Text] [Related]
19. Nerve growth factor-induced migration of endothelial cells. Dollé JP, Rezvan A, Allen FD, Lazarovici P, Lelkes PI. J Pharmacol Exp Ther; 2005 Dec 15; 315(3):1220-7. PubMed ID: 16123305 [Abstract] [Full Text] [Related]
20. Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation. Atta HM, Al-Hendy A, Salama SA, Shaker OG, Hammam OA. Liver Int; 2009 Aug 15; 29(7):1022-30. PubMed ID: 19515220 [Abstract] [Full Text] [Related] Page: [Next] [New Search]